|
"shih jy"的相關文件
顯示項目 1-25 / 32 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-01 |
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis
|
Wu, SG;Ho, CC;Yang, JC;Yu, SH;Lin, YF;Lin, SC;Liao, BC;Yang, CY;Lin, YT;Yu, CJ;Chuang, YT;Liao, WY;Yap, KY;Kou, WS;Shih, JY |
| 國家衛生研究院 |
2023-11-29 |
Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: A prospective cohort study
|
Chang, GC;Chiu, CH;Yu, CJ;Chang, YC;Chang, YH;Hsu, KH;Wu, YC;Chen, CY;Hsu, HH;Wu, MT;Yang, CT;Chong, IW;Lin, YC;Hsia, TC;Lin, MC;Su, WC;Lin, CB;Lee, KY;Wei, YF;Lan, GY;Chan, WP;Wang, KL;Wu, MH;Tsai, HH;Chian, CF;Lai, RS;Shih, JY;Wang, CL;Hsu, JS;Chen, KC;Chen, CK;Hsia, JY;Peng, CK;Tang, EK;Hsu, CL;Chou, TY;Shen, WC;Tsai, YH;Tsai, CM;Chen, YM;Lee, YC;Chen, HY;Yu, SL;Chen, CJ;Wan, YL;Hsiung, CA;Yang, PC |
| 臺大學術典藏 |
2022-09-08T07:32:27Z |
The Long-Term and Mediating Effects of Mindfulness Integrated with Body-Mind-Spirit Group Therapy on Depressive Symptoms and Quality of Life Among Non-small Cell Lung Cancer Patients
|
Hsiao, FH; Lin, ZZ; Huang, FY; Lai, YM; Chen, YT; Shih, JY; CHAO-CHI HO; Yu, CJ; Hsieh, CC |
| 中山醫學大學 |
2021 |
Subsequent Antituberculous Treatment May Not Be Mandatory Among Surgically Resected Culture-Negative Pulmonary Granulomas: A Retrospective Nationwide Multicenter Cohort Study
|
Chung, CL; Huang, WC; Huang, HL; Chin, CS; Cheng, MH; Lee, MR; Lin, SH; Wang, JY; Lin, CH; Chong, IW; Shih, JY; Yu, CJ |
| 中山醫學大學 |
2021 |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
|
Chang, GC; Lam, DCL; Tsai, CM; Chen, YM; Shih, JY; Aggarwal, S; Wang, SH; Kim, SW; Kim, YC; Wahid, I; Li, RB; Lim, DWT; Sriuranpong, V; Chan, RTT; Lorence, RM; Carriere, P; Raabe, C; Cseh, A; Park, K |
| 中山醫學大學 |
2020 |
An Observational Study of AcquiredEGFRT790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan
|
Wu, SG; Chiang, CL; Liu, CY; Wang, CC; Su, PL; Hsia, TC; Shih, JY; Chang, GC |
| 中國醫藥大學 |
2015-05 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations
|
(Chiu CH)*;(Yang CT);(Shih JY);(Huang MS);(Su WC);(Lai RS);(Wang CC);(Hsiao SH);(Lin YC);(Ho CL);夏德椿(Te-Chun Hsia);(Wu MF) |
| 亞洲大學 |
2011-04 |
Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
|
余永倫;Yu, Yung-luen;Yang CH, ;Lin SB, ;Wu, CP;Shih, JY;Yang, PC |
| 國家衛生研究院 |
2009-03-24 |
Rapid efficacy assessment method for lung cancer therapy
|
nan, PK;Sher, YP;Shih, JY;Yang, PC;Wu, CW |
| 大葉大學 |
2008-12-5 |
Good Response to Gefitinib in Lung Adenocarcinoma of Complex Epidermal Growth Factor Receptor (EGFR) Mutations with the Classical Mutation Pattern.
|
Wu, SG;Chang, YL;Hsu, YC;Wu, JY;Yang, CH;Yu, CJ;Tsai, Meng-Feng;Shih, JY;Yang, PC |
| 大葉大學 |
2008-12-05 |
Good Response to Gefitinib in Lung Adenocarcinoma of Complex Epidermal Growth Factor Receptor (EGFR) Mutations with the Classical Mutation Pattern.
|
Wu, SG;Chang, YL;Hsu, YC;Wu, JY;Yang, CH;Yu, CJ;Tsai, Meng-Feng;Shih, JY;Yang, PC |
| 國家衛生研究院 |
2008-12 |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Hsu, C;Kuo, SH;Hu, FC;Cheng, AL;Shih, JY;Yu, CJ;Lin, CC;Huang, TC;Yang, PC;Yang, CH |
| 國立臺灣大學 |
2008-06 |
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy.
|
Yang, CH; Yu, CJ; Shih, JY; Chang, YC; Hu, FC; Tsai, MC; Chen, KY; Lin, ZZ; Huang, CJ; Shun, CT; Huang, CL; Bean, J; Cheng, AL; Pao, W; Yang, PC. |
| 國家衛生研究院 |
2007-12-26 |
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
|
Bean, J; Brennan, C; Shih, JY; Riely, G; Viale, A; Wang, L; Chitale, D; Motoi, N; Szoke, J; Broderick, S; Balak, M; Chang, WC; Yu, CJ; Gazdar, A; Pass, H; Rusch, V; Gerald, W; Huang, SF; Yang, PC; Miller, V; Ladany, M; Yang, CH; Pao, W |
| 國家衛生研究院 |
2007-12 |
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
|
Bean, J;Brennan, C;Shih, JY;Riely, G;Viale, A;Wang, L;Chitale, D;Motoi, N;Szoke, J;Broderick, S;Balak, M;Chang, WC;Yu, CJ;Gazdar, A;Pass, H;Rusch, V;Gerald, W;Huang, SF;Yang, PC;Miller, V;Ladanyi, M;Yang, CH;Pao, W |
| 國立臺灣大學 |
2006-12 |
The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells.
|
Su, JL; Yang, PC; Shih, JY; Yang, CY; Wei, LH; Hsieh, CY; Chou, CH; Jeng, YM; Wang, MY; Chang, KJ; Hung, MC; Kuo, ML |
| 國立臺灣大學 |
2006-03 |
Knockdown of contactin-1 expression suppresses invasion and metastasis of lung adenocarcinoma.
|
Su, JL; Yang, CY; Shih, JY; Wei, LH; Hsieh, CY; Jeng, YM; Wang, MY; Yang, PC; Kuo, ML |
| 國家衛生研究院 |
2005-11-15 |
Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma
|
Shih, JY; Tsai, MF; Chang, TH; Chang, YL; Yuan, A; Yu, CJ; Lin, SB; Liou, GY; Lee, ML; Chen, JJW; Hong, TM; Yang, SC; Su, JL; Lee, YC; Yang, PC |
| 國家衛生研究院 |
2005-01-01 |
Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes
|
Sher, YP; Shih, JY; Yang, PC; Roffler, SR; Chu, YW; Wu, CW; Yu, CL; Peck, K |
| 中國醫藥大學 |
2005-01 |
Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
|
佘玉萍(Yuh-Pyng Sher); (Shih JY); (Yang PC); (Roffler SR); (Chu YW); (Wu CW); (Yu CL); (Peck K)* |
| 國立臺灣大學 |
2005 |
Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
|
Sher, YP; Shih, JY; Yang, PC; Roffler, SR; Chu, YW; Wu, CW; Yu, CL; Peck, K. |
| 國立臺灣大學 |
2004-12 |
Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis.
|
Chang, CC; Shih, JY; Jeng, YM; Su, JL; Lin, BZ; Chen, ST; Chau, YP; Yang, PC; Kuo, ML* |
| 國立臺灣大學 |
2004-12 |
Cyclooxygenase-2 induces EP1-and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.
|
Su, JL; Shih, JY; Yen, Ml; Jeng, YM; Chang, CC; Hsieh, CY; Wei, LH; Yang, PC; Kuo, ML |
| 國家衛生研究院 |
2004-06-14 |
Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers
|
Lee, YC; Wu, CT; Shih, JY; Jou, YS; Chang, YL |
| 國家衛生研究院 |
2004-03-03 |
Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis
|
Chang, CC; Shih, JY; Jeng, YM; Su, JL; Lin, BZ; Chen, ST; Chau, YP; Yang, PC; Kuo, ML |
顯示項目 1-25 / 32 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
